Compare CVS Health Corp (CVS) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? CVS Health Corp trades at $104.01 (market cap $135.48B), while Direxion Daily Semiconductor Bear 3X Shares trades at $42.25. The key difference: CVS Health Corp pays a 2.51% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| CVS | SOXS | |
|---|---|---|
Market Cap | $135.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $106.18 | $1.61K |
52-Week Low | $58.75 | $32.50 |
Enterprise Value | $202.02B | — |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $46.65, up 14.34% on the day amid semiconductor sector volatility. Technical indicators show a neutral overall signal with bearish moving averages. The ETF is scheduled for a 1:10 stock split on July 15, 2026, and declared a $0.04 dividend for H1-2026. Recent news highlights the ETF's role in betting against the AI-driven semiconductor rally, with SOXS down significantly over six months as chip stocks surge.
The outlook for SOXS remains highly speculative, offering leveraged inverse exposure to semiconductors. Key opportunities include hedging against a potential semiconductor downturn, but risks are extreme due to the ETF's bearish structure in a strong bull market. Volatility decay and the sector's momentum pose substantial threats to long-term holders, making it suitable only for tactical, short-term trading.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
